You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 19, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Sahan Yoruc Selcuk1,2,3, Xilin Yang1,2,3, Bijie Bai1,2,3
1Electrical and Computer Engineering Department, University of California, Los Angeles, Los Angeles, CA, USA.
A new deep learning method automates Human Epidermal Growth Factor Receptor 2 (HER2) status classification in breast cancer (BC) images. This AI tool enhances diagnostic precision and evaluation speed for improved cancer treatment planning.
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
04:48Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: